MoneyWorks4Me

Tyche Inds - Quaterly Results

27 May 2023 Evaluate
The turnover is pegged at Rs. 252.88 millions for the March 2023 quarter. The mentioned figure indicates a rise of about 55.47% as against Rs. 162.65 millions during the year-ago period.Handsome Net Profit growth of 79.18% reported above the corresponding previous quarter figure of Rs. 41.05 millions to Rs. 22.91 millions.The company reported a good operating profit of 61.00 millions compared to 35.13 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 252.88 162.65 55.47 753.85 622.67 21.07 753.85 622.67 21.07
Other Income 9.40 11.99 -21.60 48.28 41.56 16.17 48.28 41.56 16.17
PBIDT 61.00 35.13 73.64 209.77 151.17 38.76 209.77 151.17 38.76
Interest 0.00 0.00 0.00 0.01 0.01 0.00 0.01 0.01 0.00
PBDT 61.00 35.13 73.64 208.56 144.23 44.60 208.56 144.23 44.60
Depreciation 4.76 4.20 13.33 17.73 17.89 -0.89 17.73 17.89 -0.89
PBT 56.24 30.93 81.83 190.83 126.34 51.04 190.83 126.34 51.04
TAX 15.19 8.02 89.40 49.13 33.04 48.70 49.13 33.04 48.70
Deferred Tax -0.47 1.13 -141.59 -1.20 -0.86 39.53 -1.20 -0.86 39.53
PAT 41.05 22.91 79.18 141.70 93.30 51.88 141.70 93.30 51.88
Equity 102.45 102.45 0.00 102.45 102.45 0.00 102.45 102.45 0.00
PBIDTM(%) 24.12 21.60 11.68 27.83 24.28 14.62 27.83 24.28 14.62
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..